Factory supply Ivabradine hydrochloride Cas 148849-67-6 with high quality and fast delivery CAS NO.148849-67-6

Professional supplier Ivabradine hydrochloride Cas 148849-67-6 with superior quality

Company profile

Wuhan Fortuna Chemical Co.,Ltd established in 2006, is a big integrative chemical enterprise being engaged in Pharmaceutical & its intermediates, Food/Feed additives, Fine chemicals in distributing the products of our own company and affiliated enterprises, are the members of Hubei E-commerce Chamber.

Our company has professional persons who major in chemical R&D and sicentific management, supply fine chemical products with high quality and close service, also supply custom-tailored products according to our clients’ requirement.

We have a positive and self-motivated management work team with a common philosophy, caring and commitment through teamwork, our team strive to achieve success in delighting our clients and ourselves. 

Since Wuhan Fortuna Chemical Co., Ltd founded, we continuously innovate our products and improve our service, sales network. Hence, we initiate the first sale mode on net in China, which is the retail trade of small package bring along wholesale of diversified management modes. Our products are exported widely to South Korea, Vietnam, Australia, Europe and South America, highly recommended by our clients.

We insist on the management creed “Market is our compass, Quality is our life, Credit is our soul”. Clients’ trust is our forward powder, their satisfaction is our struggling goal.

our competitive advantage

Guaranteed purity

High quality & competitive price

Quality control

Fast feedback

Prompt shipment

Ivabradine Hydrochloride is a cardiovascular medication that selectively inhibits the If channels in the sinoatrial node, reducing heart rate without affecting myocardial contractility. It is primarily used to:

Treat chronic heart failure (NYHA class II-IV) with elevated heart rate.

Manage stable angina pectoris in patients intolerant to beta-blockers.

Key Features:

Dosage: Typically 5–7.5 mg twice daily.

Mechanism: Lowers heart rate by slowing sinus node activity.

Side Effects: Bradycardia, visual disturbances (e.g., luminous phenomena/phosphenes), headache.

Contraindications: Severe bradycardia, acute heart failure, CYP3A4 inhibitor use (e.g., ketoconazole).

Approved by the FDA and EMA, it is marketed under brands like Corlanor® and Procoralan®. Always prescribed under medical supervision due to its narrow therapeutic window.